Hunan Nucien Pharmaceutical Co., Ltd. (688189.SH) has issued a profit warning, expecting a net loss of 260 to 360 million yuan in 2024.

Hunan Nucien Pharmaceutical Co., Ltd. (688189.SH) issued an announcement, stating that the company expects to incur a net loss attributable to the owners of the parent company in the annual results for the year 2024 compared to the same period last year. The net loss attributable to the owners of the parent company is expected to be between 260 million yuan and 360 million yuan.